Sponsors

LABORATORY MANAGEMENT ARTICLES

Management of risk: an action plan for pulling everything together

Stephen MacDonald concludes his series of articles on risk-based quality management by drawing together the various elements on which each of the previous seven articles focused.

Detection to direction: the future of precision oncology diagnostics

Advances in molecular and genomic technologies are transforming oncology diagnostics, bridging screening, risk stratification, and treatment selection into a connected model of early cancer detection.

Improving blood services with new technology in south west London

Earlier this year, South West London Pathology celebrated the installation of new analysers and automated tracking at Croydon Hospital’s essential service laboratory. Six months on, Pathology in Practice Editor Andy Myall caught up with SWLP‘s Managing Director Simon Brewer to see how the project is progressing.

Enhancing patient care with automated osmolality testing

With laboratories under pressure, automation allows staff to gain back time. Here, Megan Northam explains how her laboratory has benefited from the features of the OsmoPRO MAX Automated Osmometer.

Risk-based audit schedules and periodic review of examinations

In this seventh article in his series on risk management, Stephen MacDonald moves on to consider internal audits and periodic reviews of examinations, which are fundamental to delivering safe and reliable laboratory services.

Monitoring of lot changes, delta checks, critical results and reference range

In this sixth article in his series, Stephen MacDonald considers the need for a broader, risk-based approach, where monitoring activities are chosen and applied according to the potential for patient harm.

Surgery to slide: why pre-analytical excellence matters

Andrew Turner explains how pathology services and ultimately patients can benefit, by analysing and then optimising the pre-analytic phase.

Passionate about pathology: Debra Padgett on leading from the front

Debra Padgett, Clinical Pathology Lead and Lead Healthcare Scientist, and an IBMS Past President, discusses pathology, working towards Net Zero, and Biomedical Science Day as well as the recent refurbishment of her laboratory.

Risk-based turnaround time management: a look at some important issues

In this fifth article in his series, Stephen MacDonald focuses on the implementation of risk-based turnaround time management, which requires collaboration across laboratory and clinical teams, supported by robust IT infrastructure and real-time monitoring tools, and, most importantly, cultural change.

Risk-based quality control: planning, defining, linking and evaluating

By moving away from fixed quality control schedules and embracing a framework rooted in clinical risk and analytical performance, laboratories can tailor their quality systems to reflect real-world challenges. Here, Stephen MacDonald introduces the role of analytical performance specifications, Sigma metrics, and the MaxE(nuf) model.

Risk-based validation and verification in medical laboratories: an overview

The third in Stephen MacDonald’s latest series of articles focuses this month on the use of risk-based approaches and the application of methods such as FMEA, FTA, RCA and Process Mapping.

Process mapping, FMEA and FTA: practical approaches to risk assessment

Stephen MacDonald continues his new series on the management of risk in the pathology laboratory environment with a look at three practical approaches, process mapping, failure mode and effects analysis, and fault tree analysis.

Introduction to risk management frameworks in clinical laboratories

Stephen MacDonald returns with the first in a new series of articles. Here, he begins with an introduction to the subject of management of risk in the pathology laboratory environment.

Joined-up IT systems – Clinisys ICE Summit shows the way forward

Clinisys’ second big customer summit of 2024 saw more than 150 people gather at The Belfry to hear about the roadmap for its order communications and results reporting system, innovative use-cases, and why it all matters. Matthew Fouracre reports.

Osmolality and beyond: delivering innovation for nearly 70 years

Building innovative solutions to common laboratory challenges has been Advanced Instruments’ mission since 1955, a time when electronic automation was just beginning to be applied to laboratory methods. Throughout its 70-year history, Advanced Instruments’ osmometers have helped global clinical laboratories revolutionise workflow efficiency on the chemistry bench. Over the last two decades, this mission has expanded to microbiology, haematology, and beyond.

Responding to challenges, realising opportunities: Clinisys Customer Summit

Clinisys WinPath laboratory information system customers recently gathered at The Belfry to discuss the major challenges facing pathology, and the role of technology in addressing them. Here, Matthew Fouracre reports from a packed, but inspiring, two-day event.

Improvements to laboratory process through a molecular work area

Karl McIntyre of Liverpool Clinical Laboratories describes the improvements to pathology process and efficiency which have been delivered by a fully automated molecular work area.

Enhancing laboratory sterilisation practices: addressing challenges

Laboratory sterilisers play a key role in safe ongoing operation of the laboratory and training operators in the safe use of these machines and laboratory managers in managing the processes is more important than ever, says Keith Miller.

UK NEQAS: delivering far more than external quality assessment

Liam Whitby, President of the United Kingdom National External Quality Assessment Service (UK NEQAS) explains the reason why UK NEQAS is a world leader in EQA.

Laboratory automation: maximising benefits and reducing risks

While automation of laboratory tests and procedures can bring great efficiencies and benefits to the laboratory and to overall patient care, effective implementation of an automation project requires detailed planning strategy and evaluation, as Renato Gargiani explains.

Latest Issues

BIVDA Regulatory Affairs Seminar

Grand Hotel, Birmingham
10 - 11 February, 2026

BDIAP Molecular Pathology Study Day

10 Union Street, London, SE1 1SZ
2 March, 2026

Cell & Gene Therapy 2026

Hinxton Hall Conference Centre, Wellcome Genome Campus, Hinxton, CB10 1RQ
9-11 March, 2025

USCAP 115th Annual Meeting

Henry B. González Convention Center, San Antonio, Texas, USA
21 - 26 March, 2026

Microbiology Society Annual Conference 2026

ICC Belfast, Northern Ireland
13 - 16 April, 2026